About This Course

Managing chemotherapy-induced neutropenia in 2021 - get the latest updates to improve treatment adherence, increase patient access, and reduce clinic visits during the COVID-19 pandemic.

An interactive course aimed at healthcare professionals (oncologists, general practitioners, nurse practitioners) treating cancer patients receiving chemotherapy.

This course should take you approximately 60 minutes to complete.

Developed together with world-leading experts:

Lee Schwartzberg, MD FACP

West Cancer Center, Germantown, TN, USA

Adam Brufsky, MD PhD

University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Kashyap B Patel, MD

Carolina Blood and Cancer Care Associates, Rock Hill, SC, USA

This course has a 2-year expiry date of 15th May 2025. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed. 

Learning Objectives

By the end of this module, you should:

  • Understand the definition of febrile neutropenia in patients receiving chemotherapy

  • Appreciate the impact both for the patient and the health system

  • Be familiar with risk assessment for the development of serious complications

  • Know the treatment options

Course curriculum

    1. Welcome to the Course

    1. Navigation Instructions

    1. Take this quiz before you start

    2. Pre-Course Quiz

    1. Main Course

    1. Introduction to Final Quiz

    2. Now check how much you have learned.

    1. Download the summary sheet

    1. Course Feedback Survey

About this course

  • Free
  • 9 lessons
  • 0 hours of video content

Commercial Support

This activity is supported by an educational grant from Fresenius Kabi SwissBioSim GmbH.